ALFA Filings
Every announcement, straight from the exchange
Every Alkem Laboratories product launch announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Alkem launches NeuCeno (cenobamate), an anti-seizure medication for partial-onset seizures in adults, for the first time in India. The once-daily drug is available in six tablet strengths.
Alkem launched Renocia Exo, a patented exosome-based hair growth serum. It expands the company's dermatology portfolio with a new follicle-support therapy.
Alkem Laboratories launched India's first semaglutide single-shot pre-filled syringes starting at INR 350. This expansion follows their March 2026 launch of injection pens.
Alkem Laboratories Limited has launched 'A to Z Daily', a comprehensive multivitamin supplement for adults. Formulated with 26 vitamins, minerals, and botanicals like Ashwagandha, the FSSAI-approved product targets stress management and immunity. This launch strengthens Alkem's growing portfolio in the wellness and nutritional supplement segment.